Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Sum-rate balancing in wireless multicell and multicarrier system
Linear rod pump apparatus and method
Wood preservation
Ranking clusters and resources in a cluster
Selective-sorting harvesting machine and sorting chain including one such machine
In-building storage apparatus and method of taking article out of the same
Rotational kinetic energy output device
  Randomly Featured Patents
Solar water heating unit
Flower holder
Fire-resistant, self-adhesive rolled roofing membrane and method of making same
Relating to a flow regulator for intravenous injection device
Telephone line circuit having time-shared DTMF receivers
Portable apparatus having cable electrically connecting display unit and base unit
Method and apparatus to perform surgical reactive jamming while maintaining simultaneous tactical communications
Silver spot/palladium plate lead frame finish
Image processing apparatus having configurable processors